Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma

https://doi.org/10.1016/S0344-0338(99)80089-2Get rights and content

Summary

Bcl-2 protein blocks apoptosis and is involved in human intrahepatic bile-duct development. Formalinfixed, paraffin-embedded archival tissue from 42 HBV and HCV hepatitis [20 acute AH, 22 chronic hepatitis (CH)], 12 active cirrhosis (CR) and 20 hepatocellular carcinoma (HCC) was immunostained for bcl-2 protein.

In all cases, bcl-2 protein was detected in portal and intralobular lymphocytes but not in hepatocytes or Kupffer cells. Bcl-2 was positive in the cytoplasm of small portal bile ducts of chronic hepatitis, while it was strongly expressed in newly formed bile-ductules of the limiting plate, mainly in CH with marked activity and CR. Bcl-2 was detected in small bile ducts in only one case of acute hepatitis and was not detected in any case of HCC.

Bcl-2 seems to be involved in the regulation of growth and apoptosis of cholangiolar cells. Its expression in small bile ducts and in newly-formed ductules especially in CH with marked activity and CR, implies that the embryonic model of intrahepatic bile duct development may be recapitulated in chronic hepatic disease. Moreover, it supports evidence for the existence of the controversial long-lived stem population in the liver. Bcl-2 does not seem to be involved in hepatocarcinogenesis.

References (37)

  • JJ Cohen

    Apoptosis

    Immunology Today

    (1993)
  • SJ Korsmeyer

    Bcl-2 initiates a new category of oncogenes: regulators of cell death

    Blood

    (1992)
  • R Baer

    Bcl-2 breathes life into embryogenesis

    Am J Pathol

    (1994)
  • V Bhargava et al.

    Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity

    Am J Pathol

    (1994)
  • MP Bronner et al.

    The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model

    Am J Pathol

    (1995)
  • F Charlotte et al.

    Immunohistochemical detection of bcl-2 protein in normal and pathological human liver

    Am J Pathol

    (1994)
  • Z Chen-Levy et al.

    The bcl-2 candidate protooncogene product is a 24-kilodalton integralmembrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

    Mol Cell Biol

    (1989)
  • ML Cleary et al.

    Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a break-point-cluster region near a transcriptionally active locus on chromosome 18

    Proc Natl Acad Sci USA

    (1985)
  • M Colombel et al.

    Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers

    Am J Pathol

    (1993)
  • A Columbano et al.

    Occurence of cell death (apoptosis) during the involution of liver hyperplasia

    Lab Invest

    (1985)
  • A Desmouliere et al.

    Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar

    Am J Pathol

    (1995)
  • JW Grisham

    Migration of hepatocytes along hepatic plates and stem cell-fed hepatocyte lineages

    Am J Pathol

    (1994)
  • N Hiramatsu et al.

    Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C

    Hepatology

    (1994)
  • D Hockenbery et al.

    Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

    Nature

    (1990)
  • DM Hockenbery et al.

    Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death

    Proc Natl Acad Sci USA

    (1991)
  • D Hockenbery

    Defining apoptosis

    Am J Pathol

    (1995)
  • CC Hsia et al.

    Occurence of oval-type cells in hepatitis B-virus associated human hepatocarcinogenesis

    Hepatology

    (1992)
  • AB Kane

    Redefining cell death

    Am J Pathol

    (1995)
  • Cited by (0)

    View full text